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Abstract
Background and Purpose
There are no generally accepted criteria for the etiologic classification of intracerebral hem-
orrhage (ICH). For this reason, we have developed a set of etiologic criteria and have
applied them to a large number of patients to determine their utility.
Methods
The H-ATOMIC classification includes 7 etiologic categories: Hypertension, cerebral Amy-
loid angiopathy, Tumour,Oral anticoagulants, vascularMalformation, Infrequent causes
and Cryptogenic. For each category, the etiology is scored with three degrees of certainty:
Possible(3), Probable(2) and Definite(1). Our aim was to perform a basic study consisting of
neuroimaging, blood tests, and CT-angio when a numerical score (SICH) suggested an
underlying structural abnormality. Combinations of >1 etiologic category for an individual
patient were acceptable. The criteria were evaluated in a multicenter and prospective study
of consecutive patients with spontaneous ICH.
Results
Our study included 439 patients (age 70.8 ± 14.5 years; 61.3% were men). A definite etiol-
ogy was achieved in 176 (40.1% of the patients: Hypertension 28.2%, cerebral Amyloid
angiopathy 0.2%, Tumour 0.2%, Oral anticoagulants 2.2%, vascular Malformation 4.5%,
Infrequent causes 4.5%). A total of 7 patients (1.6%) were cryptogenic. In the remaining
58.3% of the patients, ICH was attributable to a single (n = 56, 12.7%) or the combination of
2 (n = 200, 45.5%) possible/probable etiologies. The most frequent combinations of etiolo-
gies involved possible hypertension with possible CAA (H3A3, n = 38) or with probable CAA
(H3A2, n = 29), and probable hypertension with probable OA (H2O2, n = 27). The most
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frequent category with any degree of certainty was hypertension (H1+2+3 = 80.6%) followed
by cerebral amyloid angiopathy (A1+2+3 = 30.9%).
Conclusions
According to our etiologic criteria, only about 40% patients received a definite diagnosis,
while in the remaining patients ICH was attributable to a single possible/probable etiology or
to more than one possible/probable etiology. The use of these criteria would likely help in
the management of patients with ICH.
Introduction
The epidemiology, pathogenesis, prognosis, and response to treatment of patients with Intrace-
rebral Hemorrhage (ICH) may differ depending upon the etiology. By analogy with ischemic
stroke, an etiologic classification of ICH may improve the care for patients with ICH. About
80% of cases of ICH are primary ICH (65% attributed to arterial hypertension, 15% to cerebral
amyloid angiopathy–CAA-) and the remaining 20% are considered secondary ICH [1]. How-
ever, there are no accepted criteria to attribute the etiology to a specific condition in an individ-
ual patient. Moreover, a patient may have more than one etiology, so a possible diagnosis or a
probable one is more realistic than a definite one. The use of complementary examinations to
improve the diagnostic accuracy is an undefined strategy [2]. A recent study [3] proposed an
etiologic classification of ICH called SMASH-U. In this study no degrees of certainty were pro-
vided and a classification in more than one category was not allowed.
We believe that for progress in the understanding of ICH, there should be a set of criteria
for the etiologic classification of ICH that considers the degrees of diagnostic certainty. To that
end a minimum of complementary examinations is required and an assumption that some
patients will share components of more than one etiologic category. We have developed a set
of etiologic criteria (the H-ATOMIC criteria) and have applied them to a large number of
patients in a multicenter and prospective study.
Materials and Methods
The local Ethics Committee (Hospital de la Santa Creu i Sant Pau, Barcelona, Spain) approved
the study. A signed consent from each patient or the legal representative was not deemed nec-
essary by the Committee due to the absence of a change in the routine management of the
patients and also that the data obtained were anonymous
Description of the H-ATOMIC criteria
1) Etiologic categories. According to the most frequent etiologic categories, the
H-ATOMIC classification includes the following 7 subtypes of ICH: H = arterial Hypertension,
A = CAA, T = Tumour, O = Oral anticoagulants (OA), M = arterio-venous Malformations and
cavernoma, I = Infrequent causes associated to ICH, and C = unknown cause or Cryptogenic
(by analogy with ischemic stroke classifications, this category is considered an etiologic sub-
type). The ICH to be classified is the one that constitutes current hospital admission. The only
exception is CAA, where a previous lobar hematoma assists in the classification of the current
event.
Etiology and ICH
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2) Strategy of the etiologic work up. A prerequisite for the etiological classification is to
perform a basic study as soon as possible after admission (preferably within the first 24 hours).
An extended study is at the discretion of the clinician based on clinical evaluation and findings
of the complementary explorations and neurologic status.
The basic study must include: 1) Neuroimaging: Cranial CT is the examination of choice for
the diagnosis of ICH due to it is readily available, the results are highly specific, easy to inter-
pret and rapidly obtained. Also, it is tolerated well by most patients. MRI is an acceptable alter-
native since its diagnostic accuracy is at least as high as CT [4, 5] although it is less available
and is contraindicated in some patients; 2) Blood tests: They include cell counts (red and white
cells and platelets); blood chemistry (sodium, potassium, blood glucose, urea, creatinine and
transaminase levels) and blood coagulation (activated thromboplastin time, international nor-
malized ratio and thrombin time); 3) Electrocardiogram and chest radiography. Although its
diagnostic utility is low it is done in every acute stroke patient; 4) CT-angio or other angio-
graphic modalities (MR-angio, conventional catheter angiography) when the Secondary Intra-
cerebral Hemorrhage score [6] is>2. The SICH score includes the information from a non-
enhanced CT, age, sex and relevant medical history (arterial hypertension, impaired coagula-
tion) and ranges from 0 to 6; a SICH score>2 successfully predicts a given ICH patient’s risk
of having an underlying vascular etiology. It is best to obtain the angiographic information as
soon as possible (ideally immediately after the diagnostic CT) but the clinician must decide
when the best moment is to perform this examination. However, the basic study is not consid-
ered complete in patients with a SICH score>2 until the angiographic study is completed. The
absolute or relative contraindications of this examination should be taken into account also.
The etiologic classification may be made at discharge, or before if the patient dies during
hospital admission. However, the final diagnosis may be delayed up to 3 months after ICH, if a
follow-up neuroimaging study or any new relevant information changes the etiologic category
within this period. Typical examples are a vascular abnormality (arterio-venous malformation,
dural fistula) which needs a delayed angiography, a cavernomatous malformation which needs
a follow-up MR or an ICH that is suspicious of harbouring a tumour and that will be better
depicted by a follow-up CT or MR.
The extended etiologic work up may include any or all of the following: 1) Vascular imag-
ing, when it is necessary to rule out an underlying vascular lesion that is suspected regardless of
the SICH score. In some patients, more than one angiographic examination may be needed,
and arterial as well as venous imaging (when venous thrombosis is suspected) may be advis-
able; 2) A MRI with gradient-echo sequence to depict microbleeds and siderosis that may be
supportive of CAA, hypertensive angiopathy or both [7]; 3) A delayed neuroimaging or a
repeated angiographic examination (that must be performed within the 3 months after the
onset of ICH) when it is likely that an underlying lesion will be better detected after reabsortion
of blood; 4) Transthoracic echocardiography and/or a blood pressure map for the diagnosis of
prior arterial hypertension; 5) Quantitative or qualitative measurement of the use of illegal
drugs in urine; 6) Cerebrospinal fluid analysis when vasculitis is suspected; 7) Biopsy or patho-
logical examination of specimen obtained by surgical evacuations or at autopsy; 8) Screening
for a primary cancer when metastasis is suspected; 9) Contrast-CT or contrast-MRI or PET
when a primary tumour or metastasis is suspected.
3) Degree of certainty of the etiologic classification. Each of the above etiologic catego-
ries is scored with a degree of certainty of Definite (1), Probable (2) and Possible (3). When
more than one category is scored, the letters follow the order of the acronym H-ATOMIC. For
example, T2O2 is correct but O2T2 is incorrect.
A patient can be scored as “definite” in only one etiologic category, because the category of
'1' implies that there are no other '2' or '3' etiologies. For example, M1 means that a patient has
Etiology and ICH
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a definite arterio-venous malformation but there is no possible or probable etiology regarding
hypertension, CAA, tumour, OA or infrequent causes. A patient can be classified as '3' or '2' in
one or more etiologic categories, provided no definite diagnosis has been made. For example, a
patient scored as H3A3O3 means that the patient has possible hypertensive, CAA and OA-
related ICH.
4) Definitions of each etiologic category. H (Hypertensive ICH, see Table 1). Definite
hypertensive ICH (H1). The following criteria must be fulfilled. 1) The patient had prior arte-
rial hypertension. If the patient or family members do not know whether the patient was
hypertensive prior to the ICH, this condition is fulfilled if electrocardiogram or transthoracic
echocardiography show typical findings associated with left ventricle hypertrophy, or if arterial
hypertension is demonstrated beyond 7 days after ICH (with at least two measurements above
140/90 mmHg in a patient not receiving blood pressure lowering drugs or if the patient needs
antihypertensive treatment to maintain blood pressure under 140/90 mmHg); 2) Blood pres-
sure was higher than 140 (systolic) and/or 90 mmHg (diastolic) in any measurement per-
formed within the first 6 hours after admission. If blood-pressure-lowering agents have been
administered before admission and blood pressure measurement is believed to be reliable, a
measurement>140/90 mmHg before admission is useful also; 3) The hemorrhage is located
deeply (thalamus, putamen, pallidus, caudate, internal capsule, deep white matter, isolated
intraventricular hemorrhage, pons, cerebellum); 4) There is no other '3', '2' or '1' etiology. The
presence of deep-located microbleeds is considered supportive but not required for the
diagnosis.
H2: Probable hypertensive ICH. The patient had prior arterial hypertension (or it was dem-
onstrated as described above) and has two out of three of the other criteria. H3: Possible hyper-
tensive ICH. The patient had prior arterial hypertension (or it was demonstrated as described
above) and has one out of three of the other criteria. When there is no information about prior
arterial hypertension, but the patient fulfills two or three of the other criteria, the classification
is also possible hypertensive ICH.
Table 1. Etiologic classification of ICH attributed to Arterial Hypertension.
H
score
Prior Arterial
Hypertension
Evidence of Arterial
Hypertension
Admission Blood Pressure >140/90
mmHg
Deep
location
Alternative
cause
H1 + +/- + + -
H1 - + + + -
H2 + +/- + + +
H2 + +/- - + -
H2 + +/- + - -
H2 - + + + +
H2 - + - + -
H2 - + + - -
H3 + +/- + - +
H3 + +/- - + +
H3 + +/- - - -
H3 - + + - +
H3 - + - + +
H3 - + - - -
H3 - - + + -
H3 - - + + +
doi:10.1371/journal.pone.0156992.t001
Etiology and ICH
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A (Cerebral amyloid angiopathy, see Table 2). We have adopted the validated Boston crite-
ria for CAA as possible (A3), probable (A2) and definite (A1) CAA [8] with the modification
proposed by Linn et al. regarding the presence of siderosis [9]. This means that a definite diag-
nosis (A1) can be achieved only with a full postmortem examination. Also, for a patient aged
55 with a lobar hemorrhage, at least possible etiology ('A3') should be scored (unless “other
cause of hemorrhage or superficial siderosis” exists). We require also the absence of any other
condition listed in the “Infrequent” category that is clearly related to the current lobar, cortical,
or corticosubcortical hemorrhage.
T (Tumour, Tables 3 and 4). This etiology is suspected typically by neuroimaging when
there is contrast enhancement, when the lesion is heterogeneous and when the amount of
edema is higher than expected for the time elapsed from onset to neuroimaging. The presence
of metastasis in other organs, the presence of a solid cancer outside the central nervous system
and the increase in tumour marker levels should raise clinical suspicion also. The criteria are
different for primary tumours or metastatic tumours. The etiology may be delayed in some
cases due to the need for a follow-up neuroimaging a few weeks or up to 3 months after onset.
Primary tumour: T1: A primary tumour as a definite cause of ICH requires: A compatible
lesion on neuroimaging; a positive biopsy; absence of an alternative etiology of any degree of
certainty. T2: A primary tumour as a probable cause of ICH requires: A compatible lesion on
neuroimaging; no positive biopsy; the absence of an alternative definite etiology. T3: A primary
tumour as a possible cause of ICH requires: A compatible lesion on neuroimaging; no positive
biopsy; an alternative possible or probable etiology. Metastatic tumour:
Metastatic tumour. T1: A metastatic tumour as a definite cause of ICH requires: A primary
solid cancer; one lesion with a positive biopsy or more than 1 brain lesion without a positive
lesion; absence of an alternative etiology of any degree of certainty. T2: A metastatic tumour as
Table 2. Classification of ICH attributed to CAA (modified Boston criteria).
CAA score Postmortem
examinationa
Pathologic tissue
(evacuated hematoma or
cortical biopsy)
Lobar, cortical, or
subcortical
hemorrhage
Age  55y Other diagnostic lesion (A1, A2a)
Other cause of hemorrhage or
siderosis (A2b, A3)
b
A1 + +/- + + -
A2A with
supporting
pathology
- + + + -
A2B - - +
c or d + -
A3 - - +
e or f + -
A1: CAA deﬁnite
A2A: CAA probable with supporting pathology
A2B: CAA probable
A3: CAA possible
a. Full postmortem examination demonstrating: 1) Lobar, cortical, or corticosubcortical hemorrhage; 2) Severe CAA with vasculopathy; and 3) Absence of
other diagnostic lesion
b. Other causes of intracerebral hemorrhage: excessive warfarin (INR>3); antecedent head trauma or ischemic stroke; CNS tumour, vascular
malformation, or vasculitis; and blood dyscrasia or coagulopathy. (INR>3 or other nonspeciﬁc laboratory abnormalities permitted for diagnosis of possible
CAA.) [8]
c. Multiple hemorrhages restricted to lobar, cortical, or corticosubcortical regions (cerebellar hemorrhage allowed)
d. Single lobar, cortical, or corticosubcortical hemorrhage and focal (restricted to 3 or fewer sulci) or disseminated (affecting at least 4 sulci) superﬁcial
siderosis
e. Single lobar, cortical, or corticosubcortical hemorrhage
f. Focal (restricted to 3 or fewer sulci) or disseminated (affecting at least 4 sulci) superﬁcial siderosis [9].
doi:10.1371/journal.pone.0156992.t002
Etiology and ICH
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a probable cause of ICH requires: A primary solid cancer and 1 brain lesion; no positive biopsy;
absence of an alternative definite etiology. T3: A metastatic tumour as a possible cause of ICH
requires: Either a solid primary cancer with one brain lesion or no primary cancer with more
than one brain lesion; no positive biopsy; if there is more than one lesion, no alternative etiol-
ogy is diagnosed; if there is one lesion together with a known primary cancer, there is an alter-
native etiology with any degree of certainty.
O (Oral anticoagulants, Tables 5 and 6). The classification distinguishes between ICH
caused by antivitamin K (AVK) OA and by new OA (NOAC).
For a diagnosis with any degree of certainty of ICH related to AVK a patient must be receiv-
ing AVK treatment. The diagnosis is definite (O1) when INR is2 and there is no alternative
etiology of any degree of certainty. The diagnosis is probable (O2) when INR is2 but a possi-
ble or probable alternative etiology exists or when INR is<2 and no alternative etiology exists.
Finally, the diagnosis is possible (O3) when INR is<2 and an alternative possible or probable
etiology exists.
A patient with a lobar hemorrhage who is receiving AVK has a possible or probable CAA
when INR is under 3. Therefore, a patient with a lobar hemorrhage and an INR 2–3 should be
classified as A3O2 (or A3O3 if INR is<2).
For a diagnosis with any degree of certainty of ICH related to NOAC, a patient must be
receiving NOAC treatment. The diagnosis is definite (O1) when blood coagulation tests are
altered in any way and there is no alternative etiology of any degree of certainty. The diagnosis
is probable (O2) when the blood coagulation tests are altered in any way and a possible or prob-
able alternative etiology is made, or when coagulation blood tests are normal and there is no
alternative etiology. Finally, the diagnosis is possible (O3) when blood coagulation tests are nor-
mal and an alternative possible or probable etiology exists.
M (arterio-venous Malformation and cavernoma, Table 7). M1: The definite diagnosis of
vascular malformation requires: The angiographic demonstration of an arterio-venous malfor-
mation (with either conventional catheter angiography, CT-angio or MR-angio), or a MRI
lesion highly suggestive of a cavernoma (a delayed MRI 1–3 months after ICH may be pre-
ferred for a precise diagnosis); absence of an alternative etiology of any degree of certainty.
M2: The probable diagnosis of vascular malformation requires: The angiographic demon-
stration of an arterio-venous malformation (with either conventional catheter angiography,
Table 3. Classification of ICH attributed to a primary tumour ('T').
Primary tumour score Suspicious lesion Positive biopsy Alternative cause
T1 + + -
T2 + - -
T3 + - +
doi:10.1371/journal.pone.0156992.t003
Table 4. Classification of ICH attributed to a metastatic tumour ('T').
Metastatic tumour score Known primary solid cancer Number of lesions Positive biopsy Alternative cause
T1 + >1 - -
T1 + 1 + -
T2 + 1 - -
T2 + >1 - +
T3 - >1 - -
T3 + 1 - +
doi:10.1371/journal.pone.0156992.t004
Etiology and ICH
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CT-angio or MR-angio), or a MRI lesion highly suggestive of a cavernoma; an alternative pos-
sible or probable etiology. M3: The possible diagnosis of vascular malformation requires: Indi-
rect neuroimaging data that suggest an arterio-venous malformation, or a MRI lesion that is
not conclusive of cavernoma, or MRI is contraindicated although cavernoma is suspected.
I (Infrequent causes of ICH, Table 8). This category includes conditions that may cause an
ICH although with a relatively uncommon frequency. The presence of one of these conditions
provides a definite diagnosis (I1) when there is no alternative etiology. However, the score is
probable (I2) if an alternative possible etiology exists; and the score is possible (I3) when there
is an alternative probable etiology. For example a patient with cirrhosis and a platelet count of
10.000 is classified as I1 when there is no other etiologic condition, but as M3I2 if a cavernoma
is possible. A patient with a probable arterio-venous malformation that suffers an ICH after
cocaine use must be classified also as M2I3 (but M1 in the absence of cocaine use). A patient
receiving OAs with a platelet count of 15000 must be classified as O2I3.
The list of infrequent causes of ICH includes any of the following: Symptomatic intracere-
bral hemorrhage caused by thrombolytic treatment (intravenous or intra-arterial): a PH1, PH2
or rPH hemorrhage associated with a neurological worsening (increase of at least 4 points on
the NIHSS score) within the first 36 hours after treatment; Treatment with heparin. A patient
suffers an ICH while receiving intravenous or subcutaneous heparin at full doses and with
alteration of blood coagulation tests. For patients receiving low-molecular weight heparin at
full anticoagulant dose the etiology is definite when no alternative etiology exists, probable
when an alternative possible etiology exists and possible when an alternative probable etiology
exists; Treatment with 2 antiplatelet agents; Intracranial aneurysm (congenital, mycotic,
other causes). Requires angiographic demonstration of an aneurysm topographically related to
ICH and some amount of associated subarachnoid hemorrhage; Venous angioma and telangi-
ectasia (demonstrated by angiography or MRI and topographically related to ICH); dural
AV-Fistula (demonstrated by angiography); Cerebral venous thrombosis. Requires angio-
graphic demonstration of thrombosis of a cortical vein or a venous sinus, Cerebral vasculitis
(and other intracranial vasculopathies). Requires angiographic demonstration of typical find-
ings or pathological demonstration of an inflammatory vasculopathy or other vasculopathies
(vasoconstriction reversible syndrome, dissection, Moya-Moya, Posterior Reversible Encepha-
lopathy Syndrome, Behçet’s disease); Illegal drugs: Requires evidence (often by laboratory
tests) of the presence of drugs in blood or urine (ex: cocaine, crack, amphetamine); Conditions
Table 5. Classification of ICH attributed to antivitamin K (AVK).oral anticoagulants.
AVK The patients is receiving AVK INR Alternative cause
O1 + 2 -
O2 + 2 +
O2 + <2 -
O3 + <2 +
doi:10.1371/journal.pone.0156992.t005
Table 6. Classification of ICH attributed to new oral anticoagulants (NOAC).
NOAC The patients is receiving NOAC Blood coagulation test altered Alternative cause
O1 + + -
O2 + + +
O2 + - -
O3 + - +
doi:10.1371/journal.pone.0156992.t006
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associated with hypertensive crisis (tiramine reaction, feocromocitoma, nasal vasoconstrictors,
eclampsia, cardiac catheterization, autonomic dysreflexia syndrome in paraplegics, dental
extraction. . .); Hemorrhagic dyathesis. Diagnosis of acquired or congenital diseases that impair
coagulation (for example, hemophilia, advanced liver disease with platelet counts under
10.000, platelet diseases with counts under 10.000, afibrinogenemia, disseminated intravascular
coagulation. . .); Alcohol (chronic or acute alcohol abuse>300gr/week in the absence of any
other possible, probable or definite cause); Pituitary apoplexy (bleeding into the pituitary
gland, usually harboring and adenoma); Hyperperfusion syndrome (after carotid angioplasty,
intracranial angioplasty, thromboendarterectomy, heart transplantation, surgery of congenital
heart disease, bypass); Miscellaneous (a temporal link is necessary to consider the etiologic
role): Migraine, Spät apoplexy (delayed ICH after traumatic brain injury), methanol intoxica-
tion, wasp and scorpion bite, trigeminal nerve stimulation, exposure to cold, break-dance, elec-
troshock, and roller coaster).
C (Cryptogenic). A patient with a C-ICH is a patient without a possible, probable or definite
etiology of ICH. This category requires that the basic study has been completed. To perform or
not an extended diagnostic work-up is at the discretion of the treating physician.
Application of the H-ATOMIC criteria to a multicenter series of patients
with ICH
The local Ethics Committee approved our study in all centers (a waiver was achieved in one of
them). A signed consent from each patient or the legal representative was not deemed neces-
sary by the Committee due to the absence of a change in the routine management of the
patients and also that the data obtained were anonymous. From July 2013 to December 2014
we prospectively included consecutive patients with ICH who were older than 18 years, and
who were admitted to any of the 5 participating tertiary university hospitals during the study
period. Patients were usually admitted in any of the following Hospital Departments: Emer-
gency, Intensive Care Unit, Neurology, Neurosurgery, and Internal Medicine. We excluded
Table 7. Classification of ICH attributed to a vascular malformation (AVM = arterio-venousmalformation).
Arteriovenous Malformation
score
Angiographic
demonstration
Indirect evidence (neuroimaging) Alternative probable/possible
diagnosis
AVM
M1 + +/- -
M2 + +/- +
M3 - + +/-
Cavernoma MRI suggestive MRI non conclusive or not done (but cavernoma is
suspected)
Alternative probable/possible
diagnosis
M1 + - -
M2 + - +
M3 - + +/-
doi:10.1371/journal.pone.0156992.t007
Table 8. Classification of ICH attributed to an infrequent disease.
Infrequent cause score Infrequent cause Alternative cause
I1 + -
I2 + + (alternative is possible)
I3 + + (alternative is probable)
doi:10.1371/journal.pone.0156992.t008
Etiology and ICH
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patients with traumatic ICH. A principal investigator from each center applied the
H-ATOMIC criteria to classify the patients.
The following variables were recorded for each patient: 1) Demographic data (age, sex); 2)
Vascular risk factors and other risk factors for ICH (blood pressure, diabetes mellitus, hyper-
cholesterolemia, ischemic heart disease, previous ischemic stroke, previous ICH, primary
tumour, previous arterio-venous malformation or cavernoma, pre-treatment with antiplatelets
and anticoagulants); 3) Prior cognitive impairment; 4) Previous Rankin scale score; 5) Glasgow
coma scale score and the National Institute of Health and Stroke (NIHSS) scale score at admis-
sion; 6) Neuroimaging variables: hematoma volume at admission (by the ABC/2 method),
presence of intraventricular hemorrhage, ICH location, time to baseline CT, SICH score, any
angiographic study, MRI; 7) Blood pressure and blood glucose at admission; 8) Surgical evacu-
ation; 9) Rankin scale score at discharge and mortality during hospitalization.
Statistical analysis. The results are reported as means and standard deviations for contin-
uous quantitative variables, as median and interquartile range for quantitative ordinal data
(NIHSS and GCS scores) and as number and percentages for categorical variables. After receiv-
ing training consisting on the application of the H-ATOMIC criteria, a random selection of the
discharge reports of 29 patients were reviewed by a group of evaluators consisting of five stroke
neurology experts. After revision, consensus was reached for the etiological classification of
each patient and the percentage of agreement with the consensus for each evaluator was
calculated.
Results
We studied prospectively 466 consecutive patients. The required basic study was not per-
formed in 27 of them. Our final sample is composed by 439 patients, with a mean age of
70.9 ± 14.6, and 61.3% of them were men. As part of the extended etiologic study an angio-
graphic examination (by either CT-angio, MR-angio or conventional angiography) was per-
formed in 157 (35.7%) patients, MR in 159 (36.2%), delayed neuroimaging in 154 (35%),
echocardiography/blood pressure map in 54 (12.3%), drug screen in 23 (5.2%), CSF analysis in
14 (3.1%), biopsy or autopsy examination in 12 (2.7%), cancer screening in 38 (11.6%) and
contrast CT, contrast MRI or PET in 21 (4.7%). Table 9 provides the clinical, radiological and
prognostic characteristics of our patients.
A definite score of etiology was achieved in only 176 (40.1%) patients (Fig 1, S1 Table). A
single probable etiology (n = 34, 7.7%) or possible etiology (n = 22, 5%) was scored in 56
(12.7%) patients. An important group (n = 200, 45.5%) had a combination of two (n = 167,
38%) or more (n = 33, 7.5%) etiologies. Finally, 7 patients (1.6%) were classified as cryptogenic.
In patients with a definite etiology, hypertension was the most common etiology (n = 124,
70.5%), followed by vascular malformation (n = 20, 11.4%), infrequent causes (n = 20, 11.4%),
OAs (n = 10, 5.7%), while definite CAA (n = 1, 0.5%) and tumour (n = 1 0.5%) were very
uncommon. Only 7 patients were classified in the cryptogenic category (1.6%). Infrequent
causes consisted of intracranial aneurysms (n = 6), cerebral venous thrombosis (n = 3), intrave-
nous thrombolysis (n = 3), vasculitis (n = 1), posterior reversible encephalopathy syndrome
(n = 1), IMAO-related tiramine reaction (n = 1), reversible vasoconstriction syndrome (n = 1),
blood dyscrasia (n = 1, von-Willebrand deficiency with factor XI deficiency), ergotic intoxica-
tion (n = 1), treatment with antiplatelet agents (n = 1).
The most frequent combinations of etiologies involved possible hypertension with possible
CAA (H3A3, n = 38) or with probable CAA (H3A2, n = 29), probable hypertension with proba-
ble OA (H2O2, n = 27) and probable hypertension with possible CAA (H2A3, n = 19). Probable
hypertension was a frequent category also (H2, n = 25). See S1 Table for details.
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Hypertension (Fig 2) was present in all the degrees of certainty (definite, probable or possi-
ble) in 354 patients (80.6%); CAA in 136 (30.9%), tumour in 24 (5.4%), OAs in 73 (16.6%),
Table 9. Clinical, radiological and prognostic characteristics of patients. Values given in percentages
(unless specified).
Variable
Age (y) 70.8 ± 14.5
Sex (% men) 61.3
Hypertension 75.1
Diabetes Mellitus 21.9
Hyercholesterolemia 37.7
Ischemic heart disease 9.6
Previous ischemic stroke 10.5
Previous ICH 7.3
Known primary tumour 6.6
Known prior arteriovenous malformation or cavernoma 1
Pre-treatment with anticoagulants 17.4
Pre-treatment with any antiplatelet 26.7
Prior cognitive impairment 10.3
Previous Rankin scale 0–2 82.8
Glasgow coma scale at admission, median (percentile 25 and 75), n = 432 15 (12–15)
NIHSS score at admission, median (percentile 25 and 75), n = 378 8 (3–19)
Volume of hematoma at the baseline CT (cc) (n = 343) 34.8 (57.8)
Intraventricular hemorrhage 37.9
Location
Deep 41.7
Lobar 44.4
Massive 2.5
Cerebellum 5.2
Brainstem 2.7
Multiple 1.1
Primary intraventricular 2.3
Time from onset to baseline CT (min) 510 (1422.7)
SICH score
0 20.5
1 41.6
2 25.6
3 7.3
4 3.4
5 1.4
6 0.2
Any angiographic study 33.9
MRI 33.7
Systolic blood pressure at admission (mmHg) 169.2 (32.5)
Diastolic blood pressure at admission (mmHg) 89.9 (21.2)
Blood glucose at admission (mg/dl) 138.8 (55.2)
Surgical evacuation 10.2
Rankin at discharge  2 23
In-hospital mortality 30.4
doi:10.1371/journal.pone.0156992.t009
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vascular malformation in 31 (7.2%), infrequent causes in 52 (11.8%) and cryptogenic in 7
patients (1.6%).
Percent agreement among stroke neurologists ranged from 72.4 to 96.6%.
Discussion
H-ATOMIC is the acronym that we propose for a new etiological classification in patients with
acute non-traumatic ICH. In a multicentre study we tested this classification system on 439
patients. This classification is based on three assumptions: 1) We propose that the most com-
mon etiologies are hypertension (H), CAA (A), tumour (T), OA (O) and vascular malforma-
tion (M). There is a long list of infrequent causes (I) that may cause ICH. Also there is the
possibility of not finding any etiology (C, cryptogenic ICH). Hence, by necessity, the acronym
'H-ATOMIC'; 2) It is common to find more than one potential etiology for an individual
patient. Thus, in addition to patients with a definite etiology, there are patients who have a
combination of probable or possible etiologies; 3) The patient with ICH is often unstable dur-
ing the first hours after onset and, therefore, a basic study designed to find the cause of the ICH
must be rapid and easy to perform.
Clinicians use intuitively 4 sources of information to attribute the etiology to a specific dis-
ease [2]: Age, location, CT and MRI appearance, and the clinical context (some diseases or risk
factors may be typically associated with ICH). However there is no consensus on the diagnostic
strategy to be used and on how to combine all this information to reach a final etiologic
classification.
Fig 1. Distribution of etiologic categories in 439 patients (percentages are rounded).
doi:10.1371/journal.pone.0156992.g001
Fig 2. Degree of certainty for each category (n = 439).
doi:10.1371/journal.pone.0156992.g002
Etiology and ICH
PLOSONE | DOI:10.1371/journal.pone.0156992 June 8, 2016 11 / 15
Recently, the SMASH-U etiologic criteria [3] were proposed. There are several differences
between our proposal and the SMASH-U proposal. In SMASH-U criteria were applied retro-
spectively to 1013 patients in a single-center; A tumour etiology was not included; More than
one etiology was not allowed for a specific patient, and only the most likely cause was consid-
ered; No degree of certainty was estimated; No strict definition for each etiology was presented;
A list of "other etiologies" was not provided and not defined; Finally, no diagnostic strategy was
proposed. A head-to-head comparison between the SMASH-U and H-ATOMIC classification
schemes using the same study patients would be needed to allow comparisons of similarities
and differences between the two approaches.
According to our H-ATOMIC criteria, a definite etiology was found in only 40.1% of our
patients. As expected, arterial hypertension was the most common etiology. It was the cause
for 28.2% of the patients from the total sample and of 70.5% of the patients with a definite etiol-
ogy. Clearly, the importance of hypertension as an etiologic factor is reflected also in its contri-
bution to 80.5% of all patients when including also those patients with possible or probable
hypertensive etiology. In the SMASH-U classification[3], 35% of the patients were diagnosed
with hypertensive ICH. It is important to emphasize that hypertension is a prevalent condition
and when present it does not exclude other etiologies of ICH. For example, hypertension is
more frequent in patients with lobar ICH than in the general population [10,11] and is a risk
factor also for ICH in patients who are receiving chronic OA [12].
CAA is very difficult to make a definite diagnosis, since it requires pathologic confirmation
[8]. As a result, in patients with a lobar ICH over 55 years old and without an alternative expla-
nation, a possible or a probable CAA diagnosis can be made [9, 13]. CAA was related to etiol-
ogy in 31% of our patients: probable in 20%, possible in 10.5%, and a definite in only 0.5%.
This compares with the 20% reported by the SMASH-U study [3]. As a suggestion of relative
contribution from different etiologies, it is known that chronic hypertension may facilitate
cerebral amyloid deposition [10], and that up to 30% of patients with CAA-related ICH are
hypertensives [11, 13, 14, 15]. Amyloid deposition facilitates ICH in patients who receive OA
[16].
Either primary or metastatic tumour was uncommon as an etiology of ICH in our study.
Tumour etiology was considered with different degrees of certainty in about 5% of our
patients.
OA are often a cause of ICH [17, 18]. However, although 73 (17%) of our patients were
receiving OA, the cause of hemorrhage was considered definite in only 10 patients (2.3%) and
therefore other etiologies must be contributing to the etiology of the remaining 63 patients (in
whom OA was a possible or probable etiology). The administration of OA may be complicated
by ICH when CAA, hypertension or both coexist in the same patient [12, 16, 19].
Several vascular malformations may cause ICH, but only arterio-venous malformation and
cavernoma were considered under our "M" etiology, since other malformations such as aneu-
rysms most frequently present with subarachnoid hemorrhage. The identification of a vascular
abnormality is important due to the existence of therapeutic options to prevent recurrence. For
this reason, we think it is pertinent to add the SICH score [6] to our classification system. SICH
score uses the variables already selected by intuition, as discussed above. Up to 4.5% of our
patients had this definite diagnosis, while 2.5% had a probable or possible 'M' diagnosis.
Although it is difficult to separate the relative contribution of an infrequent cause, it was
considered to participate in 7% of patients. Finally, only 7 patients (1.6%) were considered
truly cryptogenic.
An important finding of our study is that it is difficult to attribute the ICH to a single etiol-
ogy. It is common (45.5% in our study) to find 2 or more etiologies that may contribute to
ICH, with different degrees of certainty for each etiology. Additionally, although in some
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patients (12.7% in our study) we may identify a single etiology, its degree of certainty is only
probable or possible. The H-ATOMIC criteria provide a classification that aims to use all of
the available information, by analogy with the A-S-C-O classification of ischemic stroke[20].
For example, in an 80 year-old patient who is hypertensive and is treated with OA and suffers a
lobar occipital hemorrhage, it is extremely difficult to know the relative contribution of hyper-
tension, CAA and OA [18]. In the H-ATOMIC classification all the contributing etiologies are
considered. For example, 102 patients (23%) in our study had a combination of "H" and "A" eti-
ologies, and sometimes combined with "T", "O" and "I" etiologies, as illustrated in the S1 Table).
We believe that selecting a single etiology in these patients loses important information, and
neglects the concurrence of more than one etiology of ICH in an individual patient.
ICH is a devastating disease [21]. The patient may develop hemodynamic and cardio-respi-
ratory instability in the early stage and this may interfere with reaching an etiologic diagnosis.
So it is prudent to develop a basic diagnostic strategy that is quick and simple. An angiographic
analysis, preferably a CT-angiography obtained immediately after the diagnosis, should be
made in selected patients in whom the probability of an underlying vascular malformation or
venous thrombosis is suspected according to the SICH score [6, 22]. Presently, the resolution
of CT-angio is close to conventional angiography and therefore is an excellent screening tool to
rule out vascular abnormalities with a sensitivity95% and specificity approaching 100% [23].
Previous studies using conventional catheter angiography yielded few positive diagnoses in
patients with previous hypertension and in those with a deep ICH location [2]. An extended
diagnostic study may be performed in stable patients hours, days or even weeks after this basic
study, depending on the suspicion that arises after a detailed assessment of clinical data and the
results of complementary examinations. For this reason, the H-ATOMIC can provide the final
classification up to 3 months after the onset of ICH.
Our study has some limitations. This classification system is relatively complex and time-
consuming. Also it needs familiarization with the definitions of each etiologic category. There-
fore, we are planning to develop an App to be used with the aid of smart phones that would
facilitate the etiologic classification process. Finally, we agree that the basic study is too simple
and therefore has the risk of loosing important information. Although the study was conducted
in tertiary centers, the basic study can also be performed in centers that provide standard stroke
care. The recommendation for an extended study for most patients would probably increase
the number of patients with a definite score but would also lead to an increase in the number of
patients unable to complete the required study. Obviously, a major limitation is the absence of
pathologic confirmation for most patients. It is important to obtain histopathological study
when patients are operated on or post-mortem. Also, although some ICH topographies may
point to an etiology, other locations may be caused by several etiologies.
We strongly believe that there is a need for consensus in classifying the etiology of patients
with ICH. This has important implications in our daily care of patients and in designing treat-
ment and research protocols. It is plausible that epidemiology, prognosis, pathogenesis and
treatment of sporadic ICH differ among different etiologies. Recent international guidelines
[24, 25] do not offer basically any guidance on how to investigate ICH etiology. Hopefully, the
prospective application of the H-ATOMIC criteria in a large and different cohort will confirm
our results and further refine these criteria.
Supporting Information
S1 Table. List of all etiologic classifications in descending order of frequency.
(DOC)
Etiology and ICH
PLOSONE | DOI:10.1371/journal.pone.0156992 June 8, 2016 13 / 15
Acknowledgments
We thank Prof. William Stone for his helpful comments in copyedition of the manuscript. We
also wish to thank Dr. Fernando Muñoz, Dr. Leopoldo Higa, Dr. Ivan Díaz, Dr. Fernando
Fayos, Dra. Celia Painous, Dra. Elba Pascual, Dra. Belén Civantos, Dr. Gerardo Ruiz Ares, Dra.
Angela García Gallardo.
Author Contributions
Conceived and designed the experiments: JM-F RD-M LP-S AM-D PC-R. Performed the
experiments: LP-S AM-D PC-R RM EJ-X BF LD FP SA-R. Analyzed the data: JM-F RD-M LP-
S AM-D PC-R. Wrote the paper: JM-F RD-M LP-S AM-D PC-R RM EJ-X BF LD FP SA-R.
References
1. Aguilar MI, FreemanWD. Spontaneous intracerebral hemorrhage. Semin Neurol. 2010; 30:555–564.
doi: 10.1055/s-0030-1268865 PMID: 21207348
2. Cordonnier C, Klijn CJ, van Beijnum J, Al-Shahi Salman R. Radiological investigation of spontaneous
intracerebral hemorrhage: systematic review and trinational survey. Stroke. 2010; 41:685–690. doi: 10.
1161/STROKEAHA.109.572495 PMID: 20167915
3. Meretoja A, Strbian D, Putaala J, Curtze S, Haapaniemi E, Mustanoja S, et al. SMASH-U: a proposal
for etiologic classification of intracerebral hemorrhage. Stroke. 2012; 43:2592–2597. PMID: 22858729
4. Fiebach JB, Schellinger PD, Gass A, Kucinski T, Siebler M, Villringer A, et al. Stroke magnetic reso-
nance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity
of stroke imaging. Stroke. 2004; 35:502–506. PMID: 14739410
5. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, et al. Comparison of MRI and
CT for detection of acute intracerebral hemorrhage. JAMA. 2004; 292:1823–1830. PMID: 15494579
6. Delgado Almandoz JE, Schaefer PW, Goldstein JN, Rosand J, Lev MH, González RG, et al. Practical
scoring system for the identification of patients with intracerebral hemorrhage at highest risk of harbor-
ing an underlying vascular etiology: the Secondary Intracerebral Hemorrhage Score. AJNR Am J Neu-
roradiol. 2010; 31:1653–1660. doi: 10.3174/ajnr.A2156 PMID: 20581068
7. Greenberg SM, Al-Shahi Salman R, Biessels GJ, van BuchemM, Cordonnier C, Lee JM, et al. Out-
come markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol. 2014; 13:419–428. doi:
10.1016/S1474-4422(14)70003-1 PMID: 24581702
8. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy:
validation of the Boston criteria. Neurology. 2001; 56:537–539. PMID: 11222803
9. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial sidero-
sis in patients with cerebral amyloid angiopathy. Neurology. 2010; 74:1346–1350. doi: 10.1212/WNL.
0b013e3181dad605 PMID: 20421578
10. Rodrigue KM, Rieck JR, Kennedy KM, Devous MD Sr, Diaz-Arrastia R, Park DC. Risk factors for β-
amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol. 2013; 70:600–606.
doi: 10.1001/jamaneurol.2013.1342 PMID: 23553344
11. Ritter MA, Droste DW, Hegedüs K, Szepesi R, Nabavi DG, Csiba L, et al. Role of cerebral amyloid
angiopathy in intracerebral hemorrhage in hypertensive patients. Neurology. 2005; 64:1233–1237.
PMID: 15824353
12. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic
therapy: recent data and ideas. Stroke. 2005; 36:1588–1593. PMID: 15947271
13. Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: Recent insights
into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012; 83:124–137. doi: 10.
1136/jnnp-2011-301308 PMID: 22056963
14. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke. 1987; 18:311–324. PMID: 3551211
15. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid
angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol.
1991; 30: 637–349. PMID: 1763890
16. Rosand J, Hylek EM, O'Donnell HC, Greenberg SM. Warfarin-associated hemorrhage and cerebral
amyloid angiopathy: a genetic and pathologic study. Neurology. 2000; 55:947–951. PMID: 11061249
17. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, et al. The increasing incidence of anti-
coagulant-associated intracerebral hemorrhage. Neurology. 2007; 68:116–121. PMID: 17210891
Etiology and ICH
PLOSONE | DOI:10.1371/journal.pone.0156992 June 8, 2016 14 / 15
18. Béjot Y, Cordonnier C, Durier J, Aboa-Eboulé C, Rouaud O, Giroud M. Intracerebral haemorrhage pro-
files are changing: results from the Dijon population-based study. Brain. 2013; 136:658–664. doi: 10.
1093/brain/aws349 PMID: 23378220
19. Flaherty ML. Anticoagulant-associated intracerebral hemorrhage. Semin Neurol. 2010; 30:565–572.
doi: 10.1055/s-0030-1268866 PMID: 21207349
20. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New approach to stroke sub-
typing: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis. 2009; 27:502–508. doi: 10.
1159/000210433 PMID: 19342826
21. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and func-
tional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a sys-
tematic review and meta-analysis. Lancet Neurol. 2010; 9:167–176. doi: 10.1016/S1474-4422(09)
70340-0 PMID: 20056489
22. Delgado Almandoz JE, Schaefer PW, Falla JR, Gonzalez RG, Romero JM. Diagnostic accuracy and
yield of multidetector CT angiography in the evaluation of spontaneous intraparenchymal cerebral hem-
orrhage. AJNR Am J Neuroradiol. 2009; 30:1213–1221. doi: 10.3174/ajnr.A1546 PMID: 19342546
23. Macellari F, Paciaroni M, Agnelli G, Caso V. Neuroimaging in intracerebral hemorrhage. Stroke. 2014;
45:903–908. doi: 10.1161/STROKEAHA.113.003701 PMID: 24425128
24. Steiner T, Al-Shahi Salman R, Beer R, Beer R, Christensen H, Cordonnier C, et al. European Stroke
Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J
Stroke. 2014; 9:840–855. doi: 10.1111/ijs.12309 PMID: 25156220
25. Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, CushmanM, et al. Guidelines
for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Profession-
als From the American Heart Association/American Stroke Association. Stroke. 2015 46:2032–2060.
doi: 10.1161/STR.0000000000000069 PMID: 26022637
Etiology and ICH
PLOSONE | DOI:10.1371/journal.pone.0156992 June 8, 2016 15 / 15
